Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty's Government whether they have sufficient quantities of effective alternative vaccines for the entire UK population following the recent AstraZeneca test results.

The UK Government has secured early access to 357 million vaccines doses through agreements with seven separate vaccine developers. This includes agreements with:

• BioNTech/Pfizer for 40 million doses.
• Oxford/AstraZeneca for 100 million doses.
• GlaxoSmithKline and Sanofi Pasteur for 60 million doses.
• Novavax for 60 million doses.
• Janssen for 30 million doses.
• Valneva for 60 million doses.
• Moderna for 7 million doses.